nach oben

Reactions Weekly

Erschienen in:

01.08.2019 | Case report

Antivirals/calcium channel antagonists

Hyperkalaemia and contraindicated drug administered: 10 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

In a retrospective study of 33 patients, 10 patients (7 men and 3 women) aged 25−72 years were described, of whom 2 patients developed hyperkalaemia during treatment with sofosbuvir and daclatasvir for hepatitis C virus (HCV) infection, and 8 patients developed hyperkalaemia following concomitant administration of sofosbuvir and daclatasvir with nifedipine, carvedilol or amlodipine. Additionally, of these 10 patients, carvedilol was administered in 5 patients, which was contraindicated in HCV infection [not all dosages stated; routes, durations of treatments to reactions onset and outcomes not stated]. …

Yan T, et al. Recurrent hyperkalemia in patients with chronic kidney disease and hepatitis C treated with direct antiviral agents. BMC Infectious Diseases 19: 550, No. 1, 21 Jun 2019. Available from: URL: http://doi.org/10.1186/s12879-019-4117-x - China

Titel: Antivirals/calcium channel antagonists
Hyperkalaemia and contraindicated drug administered: 10 case reports
Publikationsdatum: 01.08.2019
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2019
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-019-65803-y

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Antivirals/calcium channel antagonists

Hyperkalaemia and contraindicated drug administered: 10 case reports

Excerpt

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2019

Prednisone/thalidomide

Carfilzomib

Technology-assisted workflow detects errors, reduces costs

Kanamycin

Tetrabenazine

Metformin-associated lactic acidosis